Laboratorio Reig Jofre (RJF.MC) Stock Price
Laboratorio Reig Jofre Price
Revenue has compounded at 7.0% per year over the past 19 years to 338.90 M EUR. Earnings per share have declined at 4.5% per year over the last 19 years. Laboratorio Reig Jofre's net margin stands at 3.1%, broadly stable from 2.5% several years earlier. Laboratorio Reig Jofre currently offers a dividend yield of about 1.54%. The payout ratio is around 31% of earnings.
Laboratorio Reig Jofre stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Laboratorio Reig Jofre business model & stock analysis
Frequently asked questions about Laboratorio Reig Jofre
Laboratorio Reig Jofre SA is a pharmaceutical company based in Spain. Their business model is focused on the research, development, and production of innovative pharmaceutical products. They specialize in the manufacturing of medicines, particularly in the areas of women's health, neurology, and hospital products. Laboratorio Reig Jofre SA aims to improve patients' quality of life by providing them with high-quality, reliable, and affordable medications. They strive to be an industry leader, constantly adapting to market demands and regulatory requirements. With a commitment to innovation and a customer-centric approach, Laboratorio Reig Jofre SA continues to make significant contributions to the pharmaceutical industry.
Laboratorio Reig Jofre SA is primarily active in the pharmaceutical industry.
The main competitors of Laboratorio Reig Jofre SA in the market include pharmaceutical companies such as Laboratorios Farmacéuticos Rovi SA, Almirall SA, and Grifols SA. These companies operate in the same industry and offer similar products and services, competing for market share and customers. With its strong presence and reputation, Laboratorio Reig Jofre SA faces tough competition from these key players in the pharmaceutical market.
Laboratorio Reig Jofre SA is a renowned pharmaceutical company with a rich history and strong background. Established in Spain, the company has been providing innovative healthcare solutions since its inception. With expertise in research, development, and manufacturing, Laboratorio Reig Jofre SA has become a leading player in the pharmaceutical industry. Its commitment to quality, safety, and efficacy has earned it a solid reputation worldwide. Over the years, the company has expanded its product portfolio, offering a wide range of medicines and healthcare products that cater to diverse medical needs. Laboratorio Reig Jofre SA's consistent growth and dedication to advancing healthcare make it an influential and trusted player in the industry.
Laboratorio Reig Jofre SA, a renowned pharmaceutical company, has achieved several significant milestones throughout its history. Notably, the company has made remarkable strides in research and development, leading to the successful launch of numerous innovative drugs and vaccines. Laboratorio Reig Jofre SA has also expanded its global presence through strategic partnerships and acquisitions, positioning itself as a key player in the international pharmaceutical industry. The company's commitment to quality and patient well-being has garnered recognition, with various certifications and awards honoring its excellence. These achievements highlight Laboratorio Reig Jofre SA's dedication to improving healthcare and its continuous pursuit of innovation in the pharmaceutical sector.
Laboratorio Reig Jofre SA is primarily present in Spain, where it is headquartered.
Laboratorio Reig Jofre SA is a company that prioritizes values and embraces a strong corporate philosophy. With a focus on integrity, innovation, and excellence, Laboratorio Reig Jofre SA aims to bring pharmaceutical solutions that improve patients' lives. They are committed to conducting business ethically and responsibly, ensuring the highest standards of quality and safety in all their products. Laboratorio Reig Jofre SA emphasizes continuous research and development, collaborating with healthcare professionals and strategic partners to deliver cutting-edge pharmaceutical solutions. This dedication to values and a robust corporate philosophy has established Laboratorio Reig Jofre SA as a trusted and respected player in the pharmaceutical industry.
5 analysts currently rate the Laboratorio Reig Jofre stock: 4 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Laboratorio Reig Jofre to generate revenue of 352.00 M EUR and earnings per share of 0.07 EUR.
The Laboratorio Reig Jofre share (RJF.MC) is listed on 5 stock exchanges, including: London (0RB1.L), Frankfurt (FEQ1.F), München (FEQ1.MU), Madrid (RJF.MC).
Laboratorio Reig Jofre SA (LRJ) is a pharmaceutical company that specializes in the manufacture of medicinal products, vaccines, and over-the-counter products. The company was founded in 1929 and is headquartered in Barcelona, Spain. LRJ is listed on the Madrid stock exchange and employs approximately 1,000 people worldwide.
The expected revenue of Laboratorio Reig Jofre is 352.00 M EUR. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Laboratorio Reig Jofre is 5.70 M EUR. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Laboratorio Reig Jofre is currently 37.14. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Laboratorio Reig Jofre stock.
The price-to-sales ratio (P/S) of Laboratorio Reig Jofre is currently 0.60. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Laboratorio Reig Jofre stock.
The Eulerpool Quality Score for Laboratorio Reig Jofre is 7/10.
The ISIN of Laboratorio Reig Jofre is ES0165359029. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Laboratorio Reig Jofre is A140EW. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Laboratorio Reig Jofre is RJF.MC. The ticker symbol is used to trade Laboratorio Reig Jofre shares on the stock exchange.
Laboratorio Reig Jofre stock
Laboratorio Reig Jofre Peer Group
Laboratorio Reig Jofre Ticker
Laboratorio Reig Jofre FIGI
All fundamentals and in-depth analysis of Laboratorio Reig Jofre
Our stock analysis for Laboratorio Reig Jofre stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Laboratorio Reig Jofre. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.